Clinical course of beta 2-microglobulin in the plasma of patients suffering from chronic renal failure under conservative therapy in relation to oral adsorbent therapy
Koide, K.; Sano, M.; Morio, K.; Takeda, F.; Ubukata, E.; Momose, T.; Toyama, J.; Sudo, M.; Inoue, N.; Koshikawa, S.
Nihon Jinzo Gakkai Shi 29(11): 1421-1428
1987
ISSN/ISBN: 0385-2385 PMID: 3330150 Document Number: 287265
Document emailed within 1 workday
Related Documents
Kumano, K.; Sakai, T.; Kuwao, S.; Ise, M. 1992: Dietary protein loading and the oral adsorbent AST-120 in the progression of chronic renal failure in the rat International Journal of Artificial Organs 15(12): 708-714Kumano, K.; Takara, S.; Izumi, H.; Shimizu, T.; Sakai, T.; Kuwao, S.; Ise, M.; Takahashi, H. 1987: The modifications of dietary protein and administration of oral adsorbent AST-120 in chronic renal failure in rats Nihon Jinzo Gakkai Shi 29(2): 185-194
Wigger, M.; Stolpe, H.J.; Adomssent, G.; Drückler, E.; Hartleib, H. 1989: A protein restricted diet in conservative therapy of chronic renal failure in children Kinderarztliche Praxis 57(4): 177-184
Belenkov, I.N.; Skvortsov, A.A.; Mareev, V.I.; Nasonova, S.N.; Sychev, A.V.; Narusov, O.I.; Baklanova, N.A.; Masenko, V.P. 2003: Clinical, hemodynamic and neurohumoral effects of long-term therapy of patients with severe chronic heart failure with beta-adrenoblocker bisoprolol Kardiologiia 43(10): 10-21
Niwa, T.; Nomura, T.; Sugiyama, S.; Miyazaki, T.; Tsukushi, S.; Tsutsui, S. 1997: The protein metabolite hypothesis, a model for the progression of renal failure: an oral adsorbent lowers indoxyl sulfate levels in undialyzed uremic patients Kidney International. Supplement 62: S23-S28
Tarantini, L.; Cioffi, G.; Opasich, C.; Di Lenarda, A.; Pulignano, G.; Del Sindaco, D.; De Feo, S.; Stefenelli, C.; Russo, P.; Catania, G. 2004: Pre-discharge initiation of beta-blocker therapy in elderly patients hospitalized for acute decompensation of chronic heart failure: an effective strategy for the implementation of beta-blockade in heart failure Italian Heart Journal: Official Journal of the Italian Federation of Cardiology 5(6): 441-449
Lillo-Ferez, M.; Dupommereulle, C.; Prieur, P.; Petrover, M. 1986: Levels of plasma beta 2-microglobulin and deposits of amyloid substance in patients under chronic hemodialysis Nephrologie 7(5): 211
Hei, Z.-q.; Li, X.-y.; Shen, N.; Pang, H.-y.; Zhou, S.-l.; Guan, J.-q. 2008: Prognostic values of serum cystatin C and beta2 microglobulin, urinary beta2 microglobulin and N-acetyl-beta-D-glucosaminidase in early acute renal failure after liver transplantation Chinese Medical Journal 121(14): 1251-1256
Bergström, J.; Ahlberg, M.; Alvestrand, A.; Fürst, P. 1987: Amino acid therapy for patients with chronic renal failure Infusionstherapie und Klinische Ernahrung 14(Suppl): 8-11
Robinson, L.G.; Paulbitski, A.H. 1972: Diet therapy and educational program for patients with chronic renal failure Journal of the American Dietetic Association 61(5): 531-538
Kurihara, I.; Yamaguchi, Y.; Soma, J.; Sato, H.; Ito, S.; Saito, T. 2000: Two aged patients with chronic renal failure and chronic disseminated intravascular coagulation secondary to aortic aneurysms: effect of continuous subcutaneous heparin infusion therapy Nihon Jinzo Gakkai Shi 42(7): 603-607
Gierek, T.; Markowski, J.ła.; Kokot, F.; Paluch, J.ła.; Wiecek, A.; Klimek, D. 2002: Electrophysiological examinations (ABR and DPOAE) of hearing organ in hemodialysed patients suffering from chronic renal failure Otolaryngologia Polska 56(2): 189-194
Manitius, A.; Manitius, J.; Niemierko, J.; Kliz, J. 1992: The effect of hypotensive nifedipine therapy on renal secretory function in hypertensive patients in the course of both compensated and non-compensated chronic renal failure Polski Tygodnik Lekarski 47(49-50): 1108-1110
Mioli, V.; Figus, S. 1982: Conservative and replacement therapy of chronic renal insufficiency Minerva Medica 73(15): 859-862
Ishida, M.; Yamada, M. 1991: Calcitonin for therapy of renal osteodystrophy due to long-term hemodialysis in patients with chronic kidney failure Nihon Rinsho. Japanese Journal of Clinical Medicine 49 Suppl: 725-731
Marks, R. 1995: Effects of pulsed beta-stimulant therapy on beta-adrenoceptors and chronotropic responsiveness in chronic heart failure Lancet 345(8954): 930
Skorliakov, A.V.; Bystrenin, M.A.; Voloshinova, E.V. 2007: The character and structure of infectious complications in patients with chronic renal failure, who received or did not receive replacement therapy (hemodialysis) Klinicheskaia Meditsina 85(10): 59-61
Di Benedetto, A.; Adinolfi, D.; Fariello, C. 2005: Integrated local management regarding patients suffering from the initial stage of chronic renal failure: NephroCare group pilot experience Giornale Italiano di Nefrologia: Organo Ufficiale Della Societa Italiana di Nefrologia 22(Suppl 31): S120-S124
Zueva, N.A.; Lipskaia, O.E.; Efimov, A.S. 2002: Effect of eprex in therapy of anemia of nephrogenic genesis in patients with chronic renal failure concurrent with diabetic glomerulosclerosis before hemodialysis Likars'ka Sprava 8: 129-132
Planz, G.; Haass, H.; Lamberts, B. 1982: Plasma catecholamine concentration in hypertensive subjects with chronic renal failure before and during treatment with the beta-receptor blocking drug metipranolol International Journal of Clinical Pharmacology Therapy and Toxicology 20(10): 469-473